MICHAEL S ANDERSON
CIK 1144178 · Chief Executive Officer · last filed 2018-08-14
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
2
Total Filings
19
Lifetime Open-Market Net
$380.7K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AVADEL PHARMACEUTICALS PLC (AVDL) Delisted | Chief Executive Officer | 248,953 | $21.64 | $5.39M | $62.9K | 8 | 2018-08-14 |
| AVADEL PHARMACEUTICALS PLC (FLML) Delisted | Chief Executive Officer | 223,250 | — | — | $317.8K | 11 | 2017-01-03 |
Recent Filings · Page 2 of 2
19 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-12-16 | AVADEL PHARMACEUTICALS PLC (FLML) Delisted | Grant (A) | +18,000 | $0 | EDGAR |
| 2016-12-16 | AVADEL PHARMACEUTICALS PLC (FLML) Delisted | Grant (A) | +30,000 | $0 | EDGAR |
| 2016-11-22 | AVADEL PHARMACEUTICALS PLC (FLML) Delisted | Buy (P) | +2,000 | $21.3K | EDGAR |
| 2016-09-07 | AVADEL PHARMACEUTICALS PLC (FLML) Delisted | Buy (P) | +2,000 | $28.2K | EDGAR |
| 2016-08-22 | AVADEL PHARMACEUTICALS PLC (FLML) Delisted | Buy (P) | +5,000 | $71.5K | EDGAR |
| 2016-08-12 | AVADEL PHARMACEUTICALS PLC (FLML) Delisted | Grant (A) | +50,000 | $0 | EDGAR |
| 2016-05-16 | AVADEL PHARMACEUTICALS PLC (FLML) Delisted | Buy (P) | +5,000 | $44.2K | EDGAR |
| 2016-03-21 | AVADEL PHARMACEUTICALS PLC (FLML) Delisted | Buy (P) | +5,000 | $55.2K | EDGAR |
| 2016-03-16 | AVADEL PHARMACEUTICALS PLC (FLML) Delisted | Buy (P) | +10,000 | $97.3K | EDGAR |
Showing 11–19 of 19
Prev
Page 2 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.